http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9512662-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15d42f684941d5b0617ca7764ebdff07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-19
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
filingDate 1994-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11fde2ca3e61f5ac71cca4d6fbeabacc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d12f23e2355524dc3adef940c8504463
publicationDate 1995-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9512662-A1
titleOfInvention Method of producing recombinant dimeric enzyme
abstract This invention relates to a method of producing a recombinant eukaryotic heterodimeric enzyme using a prokaryotic host. The method involves constructing a first DNA vector containing DNA encoding one of the subunits of the dimeric enzyme and then constructing a second DNA vector containing DNA encoding the second subunit of the enzyme. Once the DNA vectors are constructed, they are used to transform a prokaryotic host. The transformed prokaryotic host cell is then cultured under conditions appropriate for the expression of the dimeric enzyme. For example, using the method of the present invention, the heterodimeric isoform of creating kinase CKMB can be produced. This invention further relates to a method of producing a recombinant human dimeric enzyme in an active form using a prokaryotic host, the recombinant enzyme products produced using the method of the present invention, and a transformed prokaryotic host constructed by the method of the present invention.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5981249-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6174715-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0812914-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005090577-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6071733-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0812914-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03068949-A1
priorityDate 1993-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54002679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127722233
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226081
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16122514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226516522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127684899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID586
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID99282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128871932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226089

Total number of triples: 47.